hematopoietic system
|
• spleens of young (< 8mo), pre-leukemic transgenic mice are significantly enlarged
|
|
• peripheral blood hemoglobin concentrations are reduced in transgenic mice with leukemia
|
|
• 68 +/- 7% of bone marrow cells from transgenic mice with leukemia are myelocytes or promyelocytes
|
|
• platelet counts are diminished in transgenic mice with leukemia
|
|
• transgenic mice with leukemia have elevated numbers of peripheral blood WBCs, a high proportion of them early myeloid-lineage cells
|
|
• young (< 8 mo), pre-leukemic transgenic mice have elevated numbers of early myeloid cells in the red pulp of the spleen
|
immune system
| N |
• Gr-1+ cells from transgenic mice with leukemia exhibit surface expression of MHC class I markers at levels similar to that of wild-type Gr-1+ spleen cells
|
|
• spleens of young (< 8mo), pre-leukemic transgenic mice are significantly enlarged
|
|
• transgenic mice with leukemia have elevated numbers of peripheral blood WBCs, a high proportion of them early myeloid-lineage cells
|
|
• young (< 8 mo), pre-leukemic transgenic mice have elevated numbers of early myeloid cells in the red pulp of the spleen
|
neoplasm
|
• 1 of 31 (3.2%) and 4 of 27 (15%) transgenic mice developed acute premyelocytic leukemia (APML) by 12 and 24 months of age, respectively
• the average latency to APML onset is 7.5 +/- 0.8 months
• the proportion of early myeloid-lineage cells is elevated in peripheral blood of transgenic mice with leukemia
• an abnormal population of Gr-1+ CD34+ cells is present in bone marrow and blood of transgenic mice with leukemia and accounts for a large proportion (34% and 45% in 2 animals) of leukemic spleen cells; histologic examination shows this population is enriched for immature myeloid cells
• spleen cells from transgenic mice with leukemia transmit APML resulting in death of 100% of unirradiated, syngeneic (C3H xC57BL/6)F1 mice
• culture of spleen cells from leukemic mice in the presence of all trans retinoic acid (ATRA) significantly increases the proportion of histologically identified late myeloid cells relative to those in untreated cultures
|
growth/size/body
|
• spleens of young (< 8mo), pre-leukemic transgenic mice are significantly enlarged
|


Analysis Tools